Geo‐cultural Variation in MMSE Score Changes from Screening to Baseline in Alzheimer’s Disease Trials

Sayaka Machizawa, Erica R Appleman, Jessica Stenclik, Andrei Iacob, Amanda Hackebeil, Gila Barbati, Jacqueline Massa · 2025

Read Geo‐cultural Variation in MMSE Score Changes from Screening to Baseline in Alzheimer’s Disease Trials by Sayaka Machizawa, Erica R Appleman, Jessica Stenclik, Andrei Iacob, Amanda Hackebeil, Gila Barbati, Jacqueline Massa (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713965.txt.

Description

Sayaka Machizawa and six co-authors ask whether a common memory test behaves the same way around the world in Alzheimer's drug trials, in a 2025 conference paper. The test is the Mini-Mental State Examination, a short set of questions used to screen who can join a trial. Scores can creep up at the screening visit, which may hide drug effects later.

The team looked at score shifts from screening to the start of two large Phase 3 trials across six world regions. The shifts were not the same in each region. North America showed a much smaller drop than other regions, which hints at less score creep there. The authors say local culture may shape how people react to tests and placebos, so trial teams should plan for these gaps.

Catalog record

CREATORSayaka Machizawa, Erica R Appleman, Jessica Stenclik, Andrei Iacob, Amanda Hackebeil, Gila Barbati, Jacqueline Massa
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11713965

Browse the full library · About the Tower of Babel